Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Raymond James Initiates Coverage On Kymera Therapeutics with Market Perform Rating

Raymond James analyst Steven Seedhouse initiates coverage on Kymera Therapeutics (NASDAQ:KYMR) with a Market Perform rating.
byBenzinga Newsdesk
November 8, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Raymond James analyst Steven Seedhouse initiates coverage on Kymera Therapeutics (NASDAQ:KYMR) with a Market Perform rating.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0